Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Retirement. Johnson & Johnson (NYSE:JNJ ...

JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.

Johnson & Johnson (NYSE: JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...

Halozyme jumps 5.3% on second-quarter earnings and revenue beat, fueled by strong royalty growth, and a raised 2025 outlook.

JNJ lifts 2025 sales and EPS outlook on strong Q2 results, with new drug launches and MedTech gains fueling momentum.

Bayer AG (BAYRY) reported second-quarter 2025 core earnings of 35 cents per American Depositary Receipt (ADR), which ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Johnson & Johnson reported strong second-quarter 2025 earnings results wherein both top and bottom lines beat the Zacks ...

Palantir Technologies Inc. reports stellar Q2 results with soaring US revenue and strong growth across segments. Click for my ...